Nonendothelial Mesenchymal Cell-Derived McP-1 Is Required for FGF-2-Mediated Therapeutic Neovascularization: Critical Role of the Inflammatory/Arteriogenic Pathway
Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/01.atv.0000244684.23499.bf
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2006
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)